Clinical Trial Update: Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing safety and efficacy of ANG-3070 in chronic kidney disease with glomerular disease and proteinuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Glomerular Disease
• Proteinuria

Drugs mentioned

• ANG-3070

Snippet

Sponsor: Angion Biomedica Corp | Conditions: Glomerular Disease, Proteinuria | Phase 2 | Status: UNKNOWN